article
Understanding how MMR-deficient colorectal cancers drive tumour growth and avoid…
9 July 2024 | By Ellen Capon (Drug Target Review)
Understanding how MMR-deficient colorectal cancers drive tumour growth and avoid immune detection could pave the way for personalised cancer medicine.